AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Scope & Guideline
Unveiling New Horizons in Cell and Molecular Biology
Introduction
Aims and Scopes
- Cellular Mechanisms in Lung Disease:
Research articles often explore the cellular mechanisms involved in various lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. This includes studies on cellular signaling pathways, immune responses, and cellular interactions. - Molecular Pathways and Therapeutics:
The journal highlights studies that investigate molecular pathways involved in lung disease progression and resolution, as well as potential therapeutic targets for intervention. - Respiratory Infections and Inflammation:
A significant focus is placed on understanding the impact of respiratory infections (such as COVID-19) on lung health, including the inflammatory responses and potential long-term effects on lung function. - Stem Cell and Regenerative Medicine:
Research on stem cell biology, especially concerning lung repair and regeneration, is a core area, with studies exploring the roles of various stem cell types in the maintenance of lung homeostasis. - Environmental Influences on Lung Health:
The journal publishes studies examining the effects of environmental factors, such as tobacco smoke, air pollution, and microbial exposure, on lung biology and disease. - Translational Research:
There is a strong emphasis on translational research that bridges the gap between laboratory findings and clinical applications, aiming to improve therapeutic strategies for lung diseases.
Trending and Emerging
- Single-Cell Analysis Techniques:
There is a notable increase in studies utilizing single-cell RNA sequencing and other single-cell technologies to dissect the cellular heterogeneity within the lung, particularly in the context of diseases like asthma and pulmonary fibrosis. - Role of the Microbiome:
Emerging research examines the role of the lung microbiome and its interactions with host immunity, indicating a trend towards understanding how microbial communities influence lung health and disease. - Immunotherapy and Precision Medicine:
The journal is witnessing a rise in articles focused on immunotherapy and precision medicine approaches for treating respiratory diseases, reflecting a broader trend towards personalized medicine. - Long COVID and Post-Acute Sequelae:
Research addressing the long-term effects of COVID-19, including post-acute sequelae, has surged, highlighting the need to understand the mechanisms and impacts of this emerging health crisis. - Metabolic Pathways in Lung Disease:
An increasing number of studies are focusing on the metabolic pathways involved in lung diseases, linking metabolic dysregulation to disease mechanisms and potential therapeutic targets.
Declining or Waning
- Basic Mechanistic Studies:
There appears to be a waning interest in purely basic mechanistic studies without clear translational implications. Researchers are increasingly seeking to connect their findings to clinical applications. - Single-Agent Therapeutic Approaches:
The focus on single-agent therapeutic approaches is declining as there is a growing recognition of the complexity of lung diseases, prompting a shift towards combination therapies and multi-target strategies. - Traditional In Vivo Models:
There is a decreasing emphasis on traditional animal models for studying lung diseases, as researchers explore more sophisticated models, including human organoids and in vitro systems that better mimic human physiology. - Chronic Inflammation Studies:
While chronic inflammation remains a key area of interest, the frequency of studies solely focused on chronic inflammation markers without integrating them into broader disease mechanisms has decreased.
Similar Journals
Jornal Brasileiro de Pneumologia
Elevating pulmonary medicine with open-access insights.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
Pulmonology
Connecting theory to practice in the dynamic world of lung health.Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.
BMC Pulmonary Medicine
Championing unrestricted access to vital pulmonary research.BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.
Chronic Respiratory Disease
Exploring breakthroughs in respiratory health.Chronic Respiratory Disease is a leading peer-reviewed journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by SAGE Publications Ltd since its inception in 2004, this open-access journal has been at the forefront of disseminating high-quality research aimed at addressing chronic respiratory conditions. With an impressive impact factor and classified as Q1 in the 2023 category of Pulmonary and Respiratory Medicine, it ranks an admirable #45 out of 155 in Scopus, placing it in the 71st percentile of its field. This journal features a diverse range of studies, reviews, and clinical insights that cater to researchers, healthcare professionals, and students alike, encouraging the exchange of innovative ideas and practices in respiratory disease management. Operating out of London, UK, Chronic Respiratory Disease exemplifies a commitment to openness, having transitioned to open access since 2017, thereby ensuring that pivotal research is readily accessible to a global audience engaged in the improvement of respiratory health.
Zeitschrift fur Pneumologie
Elevating Standards in Pulmonary ResearchZeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.
Tuberculosis and Respiratory Diseases
Championing open access for global health insights.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Respiratory Investigation
Pioneering research for a breath of fresh air.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
RESPIRATORY RESEARCH
Bridging Research and Clinical Excellence in Respiratory CareRESPIRATORY RESEARCH is a leading open-access journal published by BMC, dedicated to advancing the field of pulmonary and respiratory medicine. Since its inception in 2000, this journal has provided a vital platform for disseminating high-quality research, covering a broad spectrum of topics from basic science to innovative clinical practices in respiratory health. With an impressive impact factor and a Q1 ranking in the Pulmonary and Respiratory Medicine category, RESPIRATORY RESEARCH is recognized for its significant contribution to the literature, currently positioned at rank #19 out of 155 in the Scopus database, highlighting its relevance and influence within the medical community. The journal’s commitment to open access ensures that all articles are freely available to researchers, professionals, and students, fostering collaboration and knowledge sharing in the field. With its convergence years spanning from 2000 to 2024, RESPIRATORY RESEARCH remains at the forefront of respiratory medicine research, making it an essential resource for all stakeholders in this vital medical domain.
Pulmonary Medicine
Advancing the Frontiers of Respiratory HealthPulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
Fostering breakthroughs in lung cellular and molecular research.AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.